Clinical Trial Update: Clinical Trial Evaluating Safety and Efficacy of Resomelagon on Dengue Infection (RESOVIR-2) [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating the safety and efficacy of Resomelagon for dengue fever (RESOVIR-2), currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever

Drugs mentioned

• Resomelagon

Snippet

Sponsor: Federal University of Minas Gerais | Conditions: Dengue Fever | Phase 2 | Status: NOT_YET_RECRUITING